← Back to patent-cliff list
Nenocorilant
Tier C — Watch / tradeNenocorilant
Corcept Therapeutics Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：GR
Indications (approved)：Neoplasm
Regional status
US
Phase II
2026-01-16
EU
Phase I
2021-08-03
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Nenocorilant?
Approved indications include: Neoplasm.
When does the Nenocorilant patent expire?
No public expiry year is available for Nenocorilant yet; this page updates once verified.
How do I get a quote for Nenocorilant intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29